Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00236405
Status:
TERMINATED
Last Update Posted:
2011-06-10
First Post:
2005-10-07
Brief Title:
PROCRIT and Short-Term Outcomes in Orthopedic Surgery
Sponsor:
Johnson Johnson Pharmaceutical Research Development LLC
Organization:
Johnson Johnson Pharmaceutical Research Development LLC
Study Overview
Official Title:
A Randomized Double-Blind Placebo Controlled Study to Evaluate the Effects of of PROCRIT Epoetin Alfa on Short-Term Outcomes in Orthopedic Subjects Undergoing Primary Unilateral Knee Arthroplasty
Status:
TERMINATED
Status Verified Date:
2010-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
The study was terminated due to poor enrollment
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare the effect of perioperative administration of PROCRIT to that of autologous blood donation on post-operative rehabilitation outcomes in patients undergoing unilateral knee surgery
Detailed Description:
The primary objective of this study is to compare the effect of perioperative administration of PROCRIT to that of preoperative autologous donation on post-operative rehabilitation outcomes in subjects undergoing primary unilateral knee arthroplasty
Secondary objectives are 1 To compare the effect of perioperative administration of PROCRIT to that of preoperative autologous donation on hemoglobin change in hemoglobin number of units transfused and transfusion rate during the study period and 2 To compare the effect of perioperative administration of PROCRIT to that of preoperative autologous donation on inpatient rehabilitation length of stay
The study will test the hypothesis that perioperative administration of PROCRIT will improve post-operative rehabilitation outcomes compared with preoperative autologous donation 40000U PROCRIT or Placebo SC in relation to surgery date Days -21 -14 -7 0 day of surgery 7 and 14
Secondary objectives are 1 To compare the effect of perioperative administration of PROCRIT to that of preoperative autologous donation on hemoglobin change in hemoglobin number of units transfused and transfusion rate during the study period and 2 To compare the effect of perioperative administration of PROCRIT to that of preoperative autologous donation on inpatient rehabilitation length of stay
The study will test the hypothesis that perioperative administration of PROCRIT will improve post-operative rehabilitation outcomes compared with preoperative autologous donation 40000U PROCRIT or Placebo SC in relation to surgery date Days -21 -14 -7 0 day of surgery 7 and 14
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None